Diatoms, as single cell eukaryotic microalgae, are rich sources of lipids, which have either beneficial or detrimental effects on the prevention and treatment of many diseases. Gas chromatography-mass spectrometry (GC-MS) identified diatom lipids with high levels of essential fatty acids (EFAs), especially polyunsaturated FAs (PUFAs) containing both omega-3 and omega-6. Nutritional values of FAs indicated possible applications in the pharmaceutical, nutraceutical, and functional food industries. Diatom FAs showed antioxidative potential on harmful radicals by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) scavenging, with high inhibition of the angiotensin-converting enzyme (ACE) that causes cardiovascular disease (CVD) and hypertension. A computational molecular docking simulation confirmed the inhibition mechanisms of FAs on ACE, with comparable levels of binding free energy to chemically synthesized ACE drugs. Findings suggested that diatom lipids showed potential for use as alternative ACE inhibitors or food supplement for CVD prevention.
Cyanobacteria are rich in phytochemicals, which have beneficial impacts on the prevention of many diseases. This study aimed to comprehensively characterize phytochemicals and evaluate multifunctional bioactivities in the ethanolic extract of the cyanobacterium Leptolyngbya sp. KC45. Results found that the extract mainly contained chlorophylls, carotenoids, phenolics, and flavonoids. Through LC–ESI–QTOF–MS/MS analysis, 38 phenolic compounds with promising bioactivities were discovered, and a higher diversity of flavonoids was found among the phenolic compounds identified. The extract effectively absorbed the harmful UV rays and showed high antioxidant activity on DPPH, ABTS, and PFRAP. The extract yielded high-efficiency inhibitory effects on enzymes (tyrosinase, collagenase, ACE, and α-glucosidase) related to diseases. Interestingly, the extract showed a strong cytotoxic effect on cancer cells (skin A375, lung A549, and colon Caco-2), but had a much smaller effect on normal cells, indicating a satisfactory level of safety for the extract. More importantly, the combination of the DNA ladder assay and the TUNEL assay proved the appearance of DNA fragmentation in cancer cells after a 48 h treatment with the extract, confirming the apoptosis mechanisms. Our findings suggest that cyanobacterium extract could be potentially used as a functional ingredient for various industrial applications in foods, cosmetics, pharmaceuticals, and nutraceuticals.
Although Thailand harbours > 100 hot springs with distinct physicochemistry for diverse microbial communities, an extensive biogeography of hot spring microbial communities has not previously been explored. Here we summarised the progression of previous research and their findings on microbial distributions using data gathered from 62 hot springs (temperature = 32°C–90°C, pH = 6.2–10.0), retrieved from 51 documents (from 1990 to 2025), spanning across 21 provinces along the northern, central, eastern, western and southern regions of Thailand. Cyanobacteriota communities were the most characterised, with Synechococcus and Phormidium as frequently reported genera among studies. Several cyanobacterial members, for example, Pseudanabaena , Synechococcus , Chroococcus and Chroococcidiopsis were reported at remarkably wide temperature ranges. For non‐photosynthetic bacteria, Pseudomonadota and Bacteroidota were the majority of the communities, while members from Bacillota were the most isolated. Pseudomonadota also harbour the widest distribution range, spanning ~70°C across sites. However, temperature measurements from some studies might not accurately reflect in situ conditions. Additionally, archaea were rarely noted in the community likely due to methodological limitations. Microbial eukaryotes, for example, green algae and diatoms, were occasionally isolated and classified but their communities remain largely uncharacterised. This review provides the first integrated overview and reference database of hot spring‐associated microorganisms in Thailand.
Chemotherapy‐induced toxicity remains a significant challenge in cancer treatment; natural product‐derived dietary supplements have attracted considerable attention as potential protective agents. Spirulina, a nutrient‐rich filamentous cyanobacterium widely used as a dietary supplement, is recognized for its antioxidant and anti‐inflammatory properties. Here, spirulina protein hydrolysate was evaluated for its protective effects against cyclophosphamide‐induced systemic toxicity in male Wistar rats aged 8 weeks at arrival. Following 1 week of acclimatization, rats were allocated to four groups ( n = 6/group): normal control, cyclophosphamide control, and two hydrolysate‐treated groups. The hydrolysate was administered orally at 3 or 6 mg/kg body weight daily for 14 days, with cyclophosphamide (200 mg/kg body weight) injected intraperitoneally on Days 7 and 14. Histopathological examination used hematoxylin and eosin staining. Cyclophosphamide exposure was associated with lower body weight and sperm viability, whereas hydrolysate‐treated rats continued to gain weight and exhibited higher sperm viability than cyclophosphamide controls ( p < 0.05). Hydrolysate supplementation shifted selected serum biochemical parameters toward normal‐control values. Serum albumin concentrations were 2.52 ± 0.18 g/dL in cyclophosphamide controls and 3.62 ± 0.23 and 3.63 ± 0.37 g/dL in the 3 and 6 mg/kg hydrolysate groups, respectively (mean ± SD; both p < 0.05 vs. cyclophosphamide controls). Histopathological examination revealed cyclophosphamide‐associated damage in the liver, kidney, lung, testis, epididymis, seminal vesicle, and prostate gland. Hydrolysate‐treated groups, particularly the high‐dose group, showed better preservation of tissue architecture and fewer inflammatory and degenerative changes. These findings suggest that spirulina protein hydrolysate may mitigate selected cyclophosphamide‐associated physiological, biochemical, and histopathological alterations, providing preliminary preclinical evidence for its potential as a supportive dietary intervention.